Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials. Issue 8 (3rd May 2021) - Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; et al.